Home / News / FAQ
FAQ

FAQ: Hydromer's Strategic Investment by JMEDTECH and New Board Leadership

FaqStaq News - Just the FAQs October 6, 2025
By FAQstaq Staff
Read Original Article →
FAQ: Hydromer's Strategic Investment by JMEDTECH and New Board Leadership

Summary

Hydromer has received a strategic investment from JMEDTECH and formed a new Board of Directors, marking a partnership to build a global medical device coating platform that enhances supply chain resilience and expands technological capabilities worldwide.

What is the main announcement in this press release?

Hydromer has received a strategic investment from JMEDTECH and has formed a new Board of Directors, creating a partnership to build a future-oriented global medical device coating platform.

Why is this partnership with JMEDTECH significant for Hydromer?

This partnership amplifies Hydromer’s technological and brand influence, connects capabilities across Asia and the Americas, and establishes a mirror-delivery network that enhances supply chain resilience and responsiveness for customers.

Who are the key leadership changes mentioned in the announcement?

Michael Torti continues as CEO & Director, working with new Chairman Jacqueline Zhang and the refreshed Board, while Braeden Lichti and George Kovalyov have departed the company.

What specific capabilities will the new global platform provide?

The platform integrates UV-curable and thermal-cure coating systems, supported by advanced coating equipment and regionalized coating services, providing comprehensive solutions spanning R&D, validation, and mass production.

How does this partnership benefit customers in the medical device industry?

Customers will benefit from enhanced supply chain resilience, greater responsiveness, and access to the broadest range of coating capabilities including automatic large-scale coating systems through the global platform.

When was this strategic investment and partnership announced?

The announcement was made on October 6, 2025.

What is Hydromer’s background and expertise in the medical device industry?

Hydromer has been a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, founded in 1980, with numerous proprietary formulations and patents worldwide.

Where is Hydromer headquartered and where does it operate?

Hydromer is domiciled in Concord, NC, and serves customers across the United States, Europe, and Asia-Pacific with facilities compliant to GMP, ISO 13485, and ISO 9001 standards.

Who should I contact for more information about Hydromer?

You can contact Hydromer Inc. at [email protected] for more information.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at NewMediaWire

Article Control ID: 243838